title: In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
authors.affiliation: University of Iowa College of Medicine, Iowa City 52242.
authors.forename: S A
authors.initials: SA
authors.lastname: Marshall
authors.forename: R N
authors.initials: RN
authors.lastname: Jones
authors.forename: P R
authors.initials: PR
authors.lastname: Murray
authors.forename: J A
authors.initials: JA
authors.lastname: Washington
authors.forename: S D
authors.initials: SD
authors.lastname: Allen
authors.forename: E H
authors.initials: EH
authors.lastname: Gerlach
authors.forename: M E
authors.initials: ME
authors.lastname: Erwin
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology*; D001420:Bacteria, Aerobic / Q000187:drug effects; D020682:Cefixime; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000494:pharmacology; D002444:Cefuroxime / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology; D024841:Fluoroquinolones; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000494:pharmacology; D015363:Quinolones / Q000494:pharmacology*
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D002939:Ciprofloxacin; D020682:Cefixime; C076246:sitafloxacin; D015242:Ofloxacin; D002439:Cefotaxime; D002444:Cefuroxime